News & Updates
The latest news and advances from the world's most exciting life science cluster.
Microsoft and its Seattle-based neighbor Adaptive Biotechnologies have been in partnership since 2018 on immuno-sequencing advancements. Now, they’re pivoting their work to collaborate on COVID-19
Boston-based biotech startup GentiBio has secured licensing deals with Seattle Children’s Research Institute and Benaroya Research Institute at Virginia Mason. The technology from both Seattle-based
Adaptive Biotechnologies pushes ahead with new Seattle HQ, showing strength of life sciences industry
Adaptive Biotechnologies is continuing with its plans to move into a 100,000-square-foot headquarters. The new facility, slated to open next year, will allow Adaptive to
Cellular therapy company Lyell Immunopharma is investing $50 million in a new 70,000 square foot manufacturing facility located in Bothell, Washington. This investment will support
CorneaGen, a Seattle-based provider of corneal transplant tissue, committed to donating $100,000 to help fund corneal transplant surgeries for underprivileged people of color in need